Vir Biotechnology, Inc. VIR
NASDAQ · United States · Health Technology
$11.39+0.21 (+1.88%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | 0.47 | 0.33 | +41.3% | $238.95M | +75.8% | -4.4%$9.17→$8.77 |
| Q1 2026 | 2026-05-06 | -0.85 | — | — | — | — | -7.4%$10.01→$9.27 |
| Q4 2025 | 2026-02-23 | -0.31 | -0.45 | +31.1% | — | — | +25.5%$7.56→$9.49 |
| Q3 2025 | 2025-11-05 | -1.17 | -0.70 | -67.1% | — | — | -2.5%$5.25→$5.12 |
| Q4 2024 | 2025-02-26 | -0.76 | -0.87 | +12.6% | — | — | — |
| Q3 2024 | 2024-10-31 | -1.56 | -1.08 | -44.4% | — | — | — |
| Q4 2023 | 2024-02-22 | -0.86 | -1.00 | +14.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.